Brian Godman

Brian Godman publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Brian Godman sits on this spectrum.

Brian Godman D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Brian Godman sits on this spectrum.

Best Publications

• Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers.

  Jakub Adamski;Brian Godman;Brian Godman;Brian Godman;Gabriella Ofierska-Sujkowska;Bogusława Osińska

  319
  Citations

• The 'Wise List' - A Comprehensive Concept to Select, Communicate and Achieve Adherence to Recommendations of Essential Drugs in Ambulatory Care in Stockholm

  Lars L. Gustafsson;Björn Wettermark;Björn Wettermark;Brian Godman;Eva Andersén-Karlsson

  282
  Citations

• Efficacy of Mobile Apps to Support the Care of Patients With Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

  Bráulio Cezar Bonoto;Vânia Eloisa de Araújo;Isabella Piassi Godói;Lívia Lovato Pires de Lemos

  273
  Citations

• Economics of myocardial perfusion imaging in Europe--the EMPIRE Study.

  S. R. Underwood;Brian Barr Godman;S. Salyani;J. R. Ogle

  227
  Citations

• Physicians' knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature

  Rabiatul Salmi Md Rezal;Mohamed Azmi Hassali;Alian A Alrasheedy;Fahad Saleem

  219
  Citations

• Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications

  Brian Godman;William Shrank;Morten Andersen;Christian Berg

  203
  Citations

• Response to the Novel Corona Virus (COVID-19) Pandemic Across Africa: Successes, Challenges, and Implications for the Future

  Olayinka O. Ogunleye;Debashis Basu;Debjani Mueller;Jacqueline Sneddon

  194
  Citations

• Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.

  Brian Barr Godman;Anna Bucsics;Patricia Vella Bonanno;Wija Oortwijn;Wija Oortwijn

  164
  Citations

• Ongoing Initiatives to Improve the Quality and Efficiency of Medicine Use within the Public Healthcare System in South Africa; A Preliminary Study.

  Johanna C. Meyer;Natalie Schellack;Jacobus Stokes;Ruth Lancaster

  164
  Citations

• Strategies to improve antimicrobial utilization with a special focus on developing countries

  Brian Godman;Brian Godman;Brian Godman;Abiodun Egwuenu;Mainul Haque;Oliver Ombeva Malande

  158
  Citations

• Are new models needed to optimize the utilization of new medicines to sustain healthcare systems

  Brian Godman;Rickard E Malmström;Eduardo Diogene;Andy Gray

  156
  Citations

• Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications.

  Brian Godman;Brian Godman;Brian Godman;Björn Wettermark;Björn Wettermark;Menno van Woerkom;Jessica Fraeyman

  151
  Citations

• Policies to enhance prescribing efficiency in europe: findings and future implications.

  Brian Godman;William Shrank;Morten Andersen;Christian Berg

  150
  Citations

• Ongoing pharmaceutical reforms in France: implications for key stakeholder groups.

  Catherine Sermet;Veronique Andrieu;Brian Godman;Brian Godman;Brian Godman;Eric Van Ganse

  149
  Citations

• Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future

  Brian Godman;Mainul Haque;Judy McKimm;Muhamad Abu Bakar

  145
  Citations

• Non-prescription sale and dispensing of antibiotics in community pharmacies in Zambia

  Aubrey Chichonyi Kalungia;Johanita Burger;Brian Godman;Juliana de Oliveira Costa

  141
  Citations

• The implementation of managed entry agreements in Central and Eastern Europe : findings and implications

  Alessandra Ferrario;Diāna Arāja;Tomasz Bochenek;Tarik Čatić

  137
  Citations

• Soft regulations in pharmaceutical policy making: an overview of current approaches and their consequences.

  Björn Wettermark;Björn Wettermark;Brian Godman;Bengt Jacobsson;Flora M. Haaijer-Ruskamp

  129
  Citations

• Use of Generics-A Critical Cost Containment Measure for All Healthcare Professionals in Europe?

  Brian Godman;William Shrank;Bjorn Wettermark;Morten Andersen

  127
  Citations

• Ongoing measures to enhance the efficiency of prescribing of proton pump inhibitors and statins in The Netherlands: influence and future implications

  Menno van Woerkom;Hans Piepenbrink;Brian Godman;Joost de Metz

  126
  Citations